Results 101 to 110 of about 49,037 (222)

Prolonged Use of Intravenous Isoniazid and Rifampin [PDF]

open access: yes, 1989
We present a case of a 55–year-old woman requiring prolonged therapy with intravenous isoniazid and rifampin secondary to extensive bowel disease. We believe that this is the first U.S.
John L. Sawyers   +3 more
core   +1 more source

Cotreatment with rifampin and ML141 reduces the number of intracellular Staphylococcus aureus [PDF]

open access: yes, 2020
Access to thesis permanently restricted.Access to abstract permanently restrictedThesis (M.S.)Department of ...
Evans, Melissa D.
core  

Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae [PDF]

open access: yes, 2018
The rpoB gene encodes the β subunit of RNA polymerase holoenzyme in Mycobacterium leprae (M. leprae). Missense mutations in the rpoB gene were identified as etiological factors for rifampin resistance in leprosy.
Ascher, DB   +23 more
core   +1 more source

Fast parallel quantification of dual drug systems via UV-VIS spectrometry – a case study with antibiotic substances

open access: yesCurrent Directions in Biomedical Engineering, 2017
Implant-based drug delivery necessitates a rigorous quantitative assessment and quality control of the drug release behavior. In this context, a fast simultaneous UV-VIS spectrometer quantification method was developed for an antibiotic dual drug system.
Eickner Thomas   +5 more
doaj   +1 more source

Fluorescent Protein Expressing Rickettsia buchneri and Rickettsia peacockii for Tracking Symbiont-Tick Cell Interactions

open access: yesVeterinary Sciences, 2016
Rickettsiae of indeterminate pathogenicity are widely associated with ticks. The presence of these endosymbionts can confound a One Health approach to combatting tick-borne diseases.
Timothy J. Kurtti   +3 more
doaj   +1 more source

Konstruksi mutasi daerah resisten rifampin (gen rpoB) dari Mycobacterium leprae pada penderita lepra di Surabaya melalui analisis genom hasil PCR

open access: yesJournal of Biological Researches, 2012
Rifampin is a key component in the chemoterapeutic regimens used to combat both leprosy and tuberculosis. Owing to exquisite rifampin susceptibility of Mycobacterium leprae, this drug is the backbone of the multidrug therapy currently recommended by WHO
E Bimo Aksono H
doaj   +1 more source

Rifampin and vaccinia DNA [PDF]

open access: yesJournal of Virology, 1977
The effect of rifampin on the replication of vaccinia DNA was studied in mouse L cells by a cytochemical techinque and by alkaline sucrose sedimentation analysis of newly synthesized viral DNA molecules. By the use of a fluorescent DNA-binding compound (Hoechst 33258), the sequential appearance, size, and location of the viral "factories" in rifampin ...
openaire   +2 more sources

The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits [PDF]

open access: yes, 1997
The objective of this study was to examine the effect of rifampin pretreatment on isoniazid-induced hepatotoxicity. For more than 25 years, it has been suggested that the concomitant administration of rifampin with isoniazid potentiates the ...
Petricca, Giorgio Maximillian
core  

Molecular basis of rifampin resistance in Mycobacterium leprae. [PDF]

open access: yes
Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene ...
Honore, N, Cole, S T
core   +1 more source

Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates

open access: yesMicroorganisms
Infections due to drug-resistant Acinetobacter baumannii strains are increasing and cause significant morbidity and mortality, especially in hospitalized and critically ill patients. A.
Justin Halim   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy